Christal Mickle
Fundador en ZEVRA THERAPEUTICS, INC. .
Fortuna: 602 023 $ al 30/04/2024
Cargos activos de Christal Mickle
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Corporate Officer/Principal | 10/10/2023 | - |
| Fundador | 30/10/2006 | - | |
| Director/Miembro de la Junta | 30/10/2006 | 15/04/2015 | |
| Director Ejecutivo | 01/06/2023 | 10/10/2023 | |
| Director de Operaciones | 30/10/2006 | 11/01/2023 | |
| Contacto de Relaciones con Inversores | 30/10/2006 | - | |
| Public Communications Contact | 18/09/2009 | - | |
| Presidente | 01/06/2023 | 10/10/2023 | |
| Secretario Corporativo | 30/10/2006 | - | |
| Treasurer | 30/10/2006 | - |
Historial de carrera de Christal Mickle
Antiguos cargos conocidos de Christal Mickle.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Corporate Officer/Principal | 01/01/2002 | 01/01/2005 |
Formación de Christal Mickle.
| University of Virginia | Graduate Degree |
| Virginia Polytechnic Institute & State University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
- Bolsa de valores
- Insiders
- Christal Mickle
- Experiencia
